Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Verified by: Allergan, May 2011
First Received: March 7, 2006 | Last Updated: May 27, 2011 | Phase: Phase 2/Phase 3 | Start Date: December 2005
Overall Status: Completed | Estimated Enrollment: 561
  • …
  • Tell a FriendPrint

The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular...

Brief Summary

The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension

  • Study Type: Interventional
  • Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
  • Study Primary Completion Date: June 2007

Intervention(s) in this Clinical Trial

  • Drug: bimatoprost

Outcome Measures for this Clinical Trial

Primary Measures

  • Lowering intraocular pressure (IOP)

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Clinical diagnosis of glaucoma or ocular hypertension in both eyes
  • Patient requires IOP-lowering drug in both eyes

Exclusion Criteria:

  • Uncontrolled medical conditions
  • Ocular seasonal allergies within the past 2 years

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Investigator Information

Lead Investigator: Allergan Industry

Additional Information

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00300443

Study ID Number: 192024-031

ClinicalTrials.gov Identifier: NCT00300443

Health Authority: United States: Food and Drug Administration

  • …
  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00300443